相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of T-antigen expression promoting glycogen synthase kinase 3 impairs merkel cell carcinoma cell growth
Roland Houben et al.
CANCER LETTERS (2022)
Merkel cell polyomavirus large T antigen binding to pRb promotes skin hyperplasia and tumor development
Megan E. Spurgeon et al.
PLOS PATHOGENS (2022)
Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma
Patrick C. Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Direct cellular reprogramming enables development of viral T antigen-driven Merkel cell carcinoma in mice
Monique E. Verhaegen et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Anti-inflammatory Potential of GSK-3 Inhibitors
Chandi C. Kandar et al.
CURRENT DRUG TARGETS (2021)
GSK-3 inhibitors: A New Class of Drugs for Alzheimer's Disease Treatment
Dilipkumar Pal et al.
CURRENT DRUG TARGETS (2021)
GSK-3 Inhibitors as New Leads to Treat Type-II Diabetes
Gowru Srivani et al.
CURRENT DRUG TARGETS (2021)
Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy
Ruijuan Du et al.
MOLECULAR CANCER (2021)
Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma
Paul Nghiem et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Aurora kinase A, a synthetic lethal target for precision cancer medicine
Pui Kei Mou et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2021)
Merkel cell carcinoma update: the case for two tumours
A. Nirenberg et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Artesunate Affects T Antigen Expression and Survival of Virus-Positive Merkel Cell Carcinoma
Bhavishya Sarma et al.
CANCERS (2020)
Merkel Cell Polyomavirus and Merkel Cell Carcinoma
Valeria Pietropaolo et al.
CANCERS (2020)
Glycogen Synthase Kinase 3β in Cancer Biology and Treatment
Takahiro Domoto et al.
CELLS (2020)
Merkel Cell Polyomavirus Small T Antigen Activates Noncanonical NF-κB Signaling to Promote Tumorigenesis
Jiawei Zhao et al.
MOLECULAR CANCER RESEARCH (2020)
Combined Aurora Kinase A (AURKA) and WEE1 Inhibition Demonstrates Synergistic Antitumor Effect in Squamous Cell Carcinoma of the Head and Neck
Jong Woo Lee et al.
CLINICAL CANCER RESEARCH (2019)
Characterization of six Merkel cell polyomavirus-positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration
David Schrama et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy
Paul Nghiem et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia
Brent M. Kuenzi et al.
SCIENTIFIC REPORTS (2019)
Intra-patient viral evolution in polyomavirus-related diseases
Dorian McIlroy et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2019)
Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response
Donglim Esther Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Phthalazinone Pyrazole Enhances the Hepatic Functions of Human Embryonic Stem Cell-Derived Hepatocyte-Like Cells via Suppression of the Epithelial-Mesenchymal Transition
Young-Jun Choi et al.
STEM CELL REVIEWS AND REPORTS (2018)
Phthalazinone Pyrazole Enhances the Hepatic Functions of Human Embryonic Stem Cell-Derived Hepatocyte-Like Cells via Suppression of the Epithelial-Mesenchymal Transition
Young-Jun Choi et al.
STEM CELL REVIEWS AND REPORTS (2018)
Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma A Preplanned Interim Analysis of a Clinical Trial
Sandra P. D'Angelo et al.
JAMA ONCOLOGY (2018)
Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC
Juergen C. Becker et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis
Jingwei Cheng et al.
PLOS PATHOGENS (2017)
Wnt and GSK3 Signaling Pathways in Bipolar Disorder: Clinical and Therapeutic Implications
Ather Muneer
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2017)
Merkel Cell Carcinoma Therapeutic Update
Nicole M. Cassler et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)
Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base
Shailender Bhatia et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
Howard L. Kaufman et al.
LANCET ONCOLOGY (2016)
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
Paul T. Nghiem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells
Sonja Hesbacher et al.
ONCOTARGET (2016)
Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base
Shailender Bhatia et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Eleonore Beurel et al.
PHARMACOLOGY & THERAPEUTICS (2015)
MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors
Todd B. Sells et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
The HSP70 Modulator MAL3-101 Inhibits Merkel Cell Carcinoma
Christian Adam et al.
PLOS ONE (2014)
Merkel Cell Polyomavirus Small T Antigen Controls Viral Replication and Oncoprotein Expression by Targeting the Cellular Ubiquitin Ligase SCFFbw7
Hyun Jin Kwun et al.
CELL HOST & MICROBE (2013)
Mechanisms of p53 Restriction in Merkel Cell Carcinoma Cells Are Independent of the Merkel Cell Polyoma Virus T Antigens
Roland Houben et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Vemurafenib Induces Senescence Features in Melanoma Cells
Sebastian Haferkamp et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells
Roland Houben et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The effect of Aurora kinases on cell proliferation, cell cycle regulation and metastasis in renal cell carcinoma
Yan Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator
Masahiro Shuda et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Phthalazinone Pyrazoles as Potent, Selective, and Orally Bioavailable Inhibitors of Aurora-A Kinase
Michael E. Prime et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Biochemical Mechanisms of Resistance to Small-Molecule Protein Kinase Inhibitors
Ratika Krishnamurty et al.
ACS CHEMICAL BIOLOGY (2010)
Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system
Bianca D. Lemos et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T Antigens
Roland Houben et al.
JOURNAL OF VIROLOGY (2010)
Quantitation of Human Seroresponsiveness to Merkel Cell Polyomavirus
Diana V. Pastrana et al.
PLOS PATHOGENS (2009)
Wnt/β-catenin signaling:: new (and old) players and new insights
He Huang et al.
CURRENT OPINION IN CELL BIOLOGY (2008)
T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus
Masahiro Shuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Clonal integration of a polyomavirus in human Merkel cell carcinoma
Huichen Feng et al.
SCIENCE (2008)
VX-680 inhibits Aurora A and Aurora B kinase activity in human cells
Rebecca K. Tyler et al.
CELL CYCLE (2007)
分享论文
